Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1966 4
1967 1
1968 2
1969 1
1971 1
1973 1
1974 3
1975 1
1976 1
1982 1
1985 1
2009 1
2011 1
2012 3
2013 7
2014 4
2015 5
2016 3
2017 8
2018 8
2019 4
2020 2
2021 3
2022 3
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Professional responsibility.
Szumski AJ. Szumski AJ. Arch Phys Med Rehabil. 1985 Apr;66(4):209-11. doi: 10.1016/0003-9993(85)90144-3. Arch Phys Med Rehabil. 1985. PMID: 3885905 No abstract available.
Microneurographic technique.
Szumski AJ. Szumski AJ. Phys Ther. 1982 Jun;62(6):873. doi: 10.1093/ptj/62.6.873. Phys Ther. 1982. PMID: 7079298 No abstract available.
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR.
Maksymowych WP, Claudepierre P, de Hooge M, Lambert RG, Landewé R, Molto A, van der Heijde D, Bukowski JF, Jones H, Pedersen R, Szumski A, Vlahos B, Dougados M. Maksymowych WP, et al. Among authors: szumski a. Arthritis Res Ther. 2021 Jan 29;23(1):43. doi: 10.1186/s13075-021-02428-8. Arthritis Res Ther. 2021. PMID: 33514428 Free PMC article.
Predictors of response to etanercept-methotrexate treatment: a post hoc logistic regression analysis of a randomized, open-label study in Latin American patients with rheumatoid arthritis.
de la Vega M, Guerra Bautista G, Xavier RM, Pacheco-Tena C, Solano G, Pedersen RD, Szumski AE, Borlenghi C, Santana K, Vlahos B. de la Vega M, et al. Among authors: szumski ae. Adv Rheumatol. 2021 Sep 8;61(1):56. doi: 10.1186/s42358-021-00213-4. Adv Rheumatol. 2021. PMID: 34496979 Clinical Trial.
Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib.
Dikranian A, Gold D, Bessette L, Nash P, Azevedo VF, Wang L, Woolcott J, Shapiro AB, Szumski A, Fleishaker D, Wollenhaupt J. Dikranian A, et al. Among authors: szumski a. Rheumatol Ther. 2022 Apr;9(2):411-433. doi: 10.1007/s40744-021-00405-w. Epub 2021 Dec 17. Rheumatol Ther. 2022. PMID: 34921355 Free PMC article.
55 results